News | ACC | February 09, 2016

Late-breaking Trial Presentations at ACC 2016

ACC late breakers

The following are the late-breaking clinical trial presentations presented at the 2016 American College of Cardiology (ACC) meeting April 2-4 in Chicago. The trials below were chosen based on the importance of their contribution to cardiovascular science. Click on the highlighted text to see the articles related to each presentation.

Joint ACC/JACC Late-Breaking Clinical Trials
April 2, 2016, 9 a.m., Main Tent (North Hall B1)

Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate Risk Patients with Aortic Stenosis: Final Results from the Randomized Placement of Aortic Transcatheter Valves (PARTNER 2A) Study. Presenter: Craig Smith. 9:05 - 9:17 am
Watch video interview on the PARTNER 2 outcomes

Blood Pressure Lowering in People at Moderate Risk. The HOPE-3 Trial. Presenter: Eva M. Lon. 9:27 - 9:37 a.m.

• Effects of Combined Lipid and BP-lowering on Cardiovascular Disease in a Moderate Risk Global Primary Prevention Population. Presenter: Salim Yusuf. 9:37 - 9:47 a.m.


Joint ACC/Journal of the American Medical Association Late-Breaking Clinical Trials
April 3, 2016, 8 a.m., Main Tent (North Hall B1)

• Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on Cardiovascular Events: Results of the ACCELERATE trial. Presenter: Stephen J. Nicholls. 8 - 8:10 a.m.

• Comparison of PCSK9 Inhibitor Evolocumab Versus Ezetimibe in Statin-intolerant Patients: The Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects 3 (GAUSS-3) Trial. Presenter: Steven E. Nissen. 8:15 - 8:25 a.m.

• Low-density Lipoprotein Cholesterol, Familial Hypercholesterolemia Mutation Status and Risk for Coronary Artery Disease. Presenter: Amit V. Khera. 8:30 - 8:40 a.m.

Reproducible Impact of a Global Mobile Health (mHealth) Mass-Participation Physical Activity Intervention on Step Count, Sitting Behavior and Weight: the Stepathlon Cardiovascular Health Study. Presenter: Anand Ganesan. 8:45 - 8:55 a.m.

• Involving Patients with Low Risk Chest Pain in Discharge Decisions: A Multicenter Trial. Presenter: Erik P. Hess. 9- 9:10 a.m.


Joint American College of Cardiology/TCT Late-Breaking Clinical Trials
April 3, 2016:

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: DEFERred stent implantation in connection with primary PCI. Presenter: Henning Kelbæk. 10:45 - 10:55 a.m.

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: iPOSTconditioning during primary PCI. Presenter: Thomas Engstrøm. 11 - 11:10 a.m.

• Effect Of Early Administration Of Intravenous Beta Blockers In Patients With ST-elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. The Early-BAMI trial. Presenter: V. Roolvink. 11:15 - 11:25 a.m.

Sapien 3 Transcatheter Aortic Valve Replacement versus Surgery in Intermediate-Risk Patients with Severe Aortic Stenosis: A Propensity-Matched Comparison of One-Year Outcomes. Presenter: Vinod H. Thourani. 11:30 - 11:40 a.m.
Watch a video interview with Thourani at ACC.16

Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS/ACC TVT Registry. Presenter: John D. Carroll. 11:45 - 11:55 a.m.

Watch video interview with Carroll at ACC.16


Joint ACC/New England Journal of Medicine Late-Breaking Clinical Trials
April 4, 2016, 8 a.m., Main Tent (North Hall B1)

Antiarrhythmic Drugs for Shock-Refractory Out-of-Hospital Cardiac Arrest: The Resuscitation Outcomes Consortium Amiodarone, Lidocaine or Placebo Study. Presenter: Peter J. Kudenchuk. 8- 8:10 a.m.

• Largest Randomized Trial Demonstrates an Effective Ablation of Atrial Fibrillation: the FIRE AND ICE Trial (NCT01490814). Presenter: Karl-Heinz Kuck. 8:15 - 8:25 a.m.

A Randomized Trial of Rate Control Versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. Presenter: A. Marc Gillinov. 8:30 - 8:40 a.m.

• The Losmapimod To Inhibit P38 MAP Kinase As a Therapeutic Target And Modify Outcomes After An Acute Coronary Syndrome (LATITUDE-TIMI 60) Trial: Primary Results Of Part A. Presenter: Michelle L. O'Donoghue. 8:45 - 8:55 a.m.

• CMX-2043 for Prevention of Contrast Induced Acute Kidney Injury: The Primary Results of the CARIN Trial. Presenter: Deepak L. Bhatt. 9 - 9:10 a.m.


Late-Breaking Clinical Trials
April 4, 2016, 10:45 a.m., Main Tent (North Hall B1)

Direct Renin-inhibition With Aliskiren Alone And In Combination With Enalapril, Compared With Enalapril, In Heart Failure (the ATMOSPHERE Trial). Presenter: John J. V. McMurray. 10:45 - 10:55 a.m.

• Effect of Ularitide on Short- and Long-Term Clinical Course of Patients with Acutely Decompensated Heart Failure: Primary Results of the TRUE-AHF Trial. Presenter: Milton Packer. 11 - 11:10 a.m.

The Final Results of the IxCell-DCM Stem Cell Trial: Transendocardial Injection of Ixmyelocel-T in Patients with Ischemic Dilated Cardiomyopathy. Presenter: Timothy D. Henry. 11:15 - 11:25 a.m.
Additional article on IxCell-DCM stem cell therapy

The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial. Presenter: Michael Robert Gold. 11:30 - 11:40 a.m.

Noninvasive Lung IMPEDANCE-Guided Pre-emptive Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial (IMPEDANCE-HF trial). Presenter: Michael Shochat. 11:45 - 11:55 a.m.


Late-Breaking Clinical Trials: Deep Dive II
April 4, 2016, 12:30 - 1:45 p.m.  Room S406a

Session will focus on key trial data from some of the top studies presented.

Related Content

ACC 2018 highlights and trends.  #acc.18, #ACC, #ACC2018
Feature | ACC | January 31, 2018
The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating.
ACC 2018 Late-Breaking Trials Announced
News | ACC | January 23, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Videos | ACC | April 03, 2017
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo
ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC | March 22, 2017
Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presente
Siemens Sensis Vibe, hemodyanamics system

Siemens released the Sensis Vibe hemodyanamics system at ACC.16. The newer system offers better integration of cath lab data into cath lab reports and the electronic medical record (EMR).

Feature | ACC | April 25, 2016 | Jon Brubaker, MBA, RCVT, Tom Watson, BS, RCVT, and Sabrina Newell MS, RCS
There were several trends seen in new cardiovascular technologies showcased on the expo floor at the 2016 American...
Videos | ACC | April 25, 2016
MD Buyline market analyst Jon Brubaker explained the new technology and trends he saw on the show floor at ACC.16. 
Videos | ACC | April 25, 2016
Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the curren
Videos | ACC | April 15, 2016
DAIC Editor Dave Fornell takes a tour of some of the trends and interesting new technologies from the vendor booths o
Videos | ACC | April 15, 2016
MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new hemodynamic system technology trends at ACC.16.

Photo courtesy of Vital Images

News | ACC | December 22, 2015
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle facto
Overlay Init